- Telehealth Visits
- Insurance plan information
Dereck H. Ko, NP, MSN
Hematology Oncology • Blood and Marrow Transplant- Telehealth Visits
- Insurance plan information
Dereck H. Ko, NP, MSN
Hematology Oncology • Blood and Marrow Transplant- Telehealth Visits
- Insurance plan information
On this page
About me
Dereck Ko is a nurse practitioner who specializes in cancers of the blood. He cares for patients as they go through bone marrow or stem cell transplant, or intensive chemotherapy. He also performs procedures used to diagnose blood cancers, including bone marrow biopsies and lumbar punctures to collect fluid from the spinal cord.
Ko earned a bachelor's degree in biochemistry from California State University, East Bay. While in nursing school, he worked as a pharmacy technician. After graduating, he worked as a registered nurse in an intensive care unit while earning a master's degree in nursing at San Jose State University. He is a certified family nurse practitioner.
Ko began his career as a nurse practitioner at the University of Southern California Norris Comprehensive Cancer Center. He joined UCSF in 2007.
In his free time, Ko enjoys hiking, working out, listening to music and walking on the beach with his dogs.
Education & training
Board certification
- Family Nurse Practitioner, American Academy of Nurse Practitioners
Degree
- MSN, San Jose State University
My expertise
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221416%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221416%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.